Serum laminin in hepatic schistosomiasis

Area of Science:

• Hepatology
• Parasitology
• Biochemistry

Background:

• Schistosomiasis is a parasitic disease affecting the liver and spleen.
• Hepatosplenic schistosomiasis represents a severe form with significant morbidity.
• Biomarkers for disease severity and progression are crucial for patient management.

Purpose of the Study:

• To investigate serum laminin levels in patients with chronic hepatic schistosomiasis.
• To correlate laminin levels with clinical parameters and other biomarkers.

Main Methods:

• Serum laminin levels were quantified in patients with hepatosplenic schistosomiasis, hepatointestinal schistosomiasis, and healthy controls.
• Percutaneous splenic pulp pressure and liver function tests were assessed.
• Levels of N-terminal propeptides of type III procollagen were measured.

Main Results:

• Mean serum laminin was significantly higher in hepatosplenic schistosomiasis patients (2.57 units/ml) compared to hepatointestinal (1.38 units/ml) and control groups (1.15 units/ml).
• A direct correlation was found between serum laminin and splenic pulp pressure in hepatosplenic patients (r=0.68).
• No significant correlation was observed between serum laminin and liver function tests or procollagen levels.

Conclusions:

• Elevated serum laminin in hepatosplenic schistosomiasis indicates increased production.
• This elevation may be linked to enlarged liver and spleen basement membranes characteristic of the disease.
• Serum laminin could serve as a potential biomarker for assessing disease severity in schistosomiasis.